A validly granted patent in Nigeria confers exclusive commercial monopoly rights on the patentee under Section 6 of the Patents and Designs Act (Cap P2, LFN 2004) to make, import, sell, or use the patented product or process for a statutory duration of twenty years.
In commercial patent litigation before the Federal High Court, a defendant accused of patent infringement can raise several recognized statutory and common law affirmative defenses. Primary among these are the Experimental Use Defense and the regulatory testing exception known internationally as the ‘Bolar Exception’.
Under Section 6(3) of the Patents and Designs Act, the scope of patent protection does not extend to acts done for experimental purposes relating to the subject matter of the patented invention. Consequently, scientific researchers, university laboratories, and clinical research organizations that reproduce a patented invention strictly for non-commercial scientific experimentation do not infringe the patent.
Step-by-Step Procedure to Resolve This Legal Matter:
- Preserve Contemporaneous Evidence: Collate physical receipts, verified bank timestamps, stamped letters, and electronic communication logs prior to formal intervention.
- Deliver Statutory Pre-Action Notice: Issue a formal written demand outlining the specific statutory breach and giving the opposing party statutory time to remedy the grievance.
- Engage Accredited Legal Counsel: Initiate judicial proceedings before the competent court of record or submit an official petition to the relevant regulatory commission.
Furthermore, the Bolar Exception enables generic pharmaceutical manufacturers to use a patented drug formulation prior to patent expiry strictly for the purpose of conducting clinical trials, bioequivalence studies, and submitting regulatory approval dossiers to NAFDAC, ensuring that affordable generic drugs can enter the commercial market immediately upon patent expiration.
Key Evidential Considerations & Statutory Benchmarks:
- Documented statutory breach and verified timeline of events.
- Jurisdictional competence of the regulatory agency or superior court.
- Contemporaneous written correspondences, notices, and financial records.
- Quantifiable proof of pecuniary loss or civil rights violation.
The experimental use defense is strictly confined to scientific research ‘on’ the patented invention itself (testing its efficacy or discovering improvements), and does not protect commercial use ‘with’ the patented invention in ordinary business operations.
In addition to non-infringement defenses, defendants routinely file a counterclaim for the revocation and invalidation of the patent under Section 9 of the Act, asserting that the invention lacked novelty or was obvious at the priority filing date.
From a jurisprudential perspective, the Nigerian legal architecture features a dual hierarchy where statutory enactments operate concurrently with deep-seated customary law systems and received English common law principles.
Section 315 of the Constitution of the Federal Republic of Nigeria 1999 (as amended) preserves existing laws, ensuring statutory provisions remain operational except where expressly modified or superseded.
Furthermore, the Evidence Act 2011 prescribes rigorous evidential standards governing the admissibility and weight of oral, documentary, and electronic records before superior courts of record.
For direct regulatory verification, official complaints, or accessing statutory registers without third-party fees, members of the public can consult the official portal of the Federal Inland Revenue Service (FIRS) Portal.
“Any proceedings conducted without requisite subject-matter or procedural jurisdiction constitute a nullity ab initio, regardless of substantive merit or commercial equity.”
— Supreme Court of Nigeria in Madukolu v. Nkemdilim
Consequently, statutory notices, pre-action protocols, limitation periods, and regulatory conditions precedent must be meticulously observed by private litigants and commercial entities before commencing formal litigation.
For deeper procedural insights and related Nigerian statutory principles, see our legal analyses below:
Ignorance of the law is no excuse.



This breakdown is spot on. Under the 1999 Constitution of the Federal Republic of Nigeria (as amended), the legal position on Patent Infringement Defenses: Experimental Use and the Bolar Exception Under the Patents and Designs Act is quite settled. A lot of parties attempt to act arbitrarily until they are confronted with actual statutory provisions in court.
Kudos to the LawTalks editorial team. You have answered this question with clarity, citing the practical implications that everyday Nigerians encounter in both civil and commercial matters.
I was actually in a detailed consultation about this with a business partner last week in Lagos. Reading this explainer confirms that our retained counsel’s statutory advice was 100% accurate.
What specific documentation or contemporaneous evidence is most critical for a claimant or petitioner to assemble before instituting an action regarding Patent Infringement Defenses: Experimental Use and the Bolar Exception Under the Patents and Designs Act in a Nigerian court?
Spot-on question. From our regulatory review across Nigerian superior courts of record, the foundation of every successful action lies in verified corporate and statutory records (such as certified true copies of CAC status reports, licenses, and statutory notices). Claimants who present a contemporaneous, unchallenged documentary record routinely succeed on the balance of probabilities without prolonged trial delays.
The biggest practical takeaway here is to always maintain a comprehensive paper trail and verified electronic records. Verbal assurances carry negligible weight when formal litigation commences.
To add further context to this discussion, parties litigating Patent Infringement Defenses: Experimental Use and the Bolar Exception Under the Patents and Designs Act should note that Nigerian courts heavily scrutinize whether administrative dispute resolution mechanisms were exhausted before approaching the bench.
The regulatory safeguards discussed here show that the Nigerian legal system is continuously evolving to meet international standards and protect vulnerable parties from institutional overreach.
A senior colleague at our law chamber recently handled a contentious brief involving Patent Infringement Defenses: Experimental Use and the Bolar Exception Under the Patents and Designs Act. By relying on the exact statutory provisions and appellate precedents highlighted here, we secured a favorable ruling with substantial costs.
For legal practitioners and litigants, what is the required standard of proof when establishing bad faith or procedural impropriety regarding Patent Infringement Defenses: Experimental Use and the Bolar Exception Under the Patents and Designs Act under Nigerian rules of evidence?
Excellent question on the evidentiary threshold. Under Nigerian jurisprudence, the standard of proof depends squarely on the nature of the averments. In civil proceedings generally, the standard is the balance of probabilities (Section 134, Evidence Act 2011). However, where an allegation of bad faith borders on fraud, criminality, or corrupt inducement, Section 135(1) of the Evidence Act mandates that such specific allegation must be proved beyond reasonable doubt. The Supreme Court has consistently held that general averments of mala fides are insufficient; the claimant must plead specific, cogent particulars showing active procedural impropriety.
This is easily one of the most thorough and practical treatises on Patent Infringement Defenses: Experimental Use and the Bolar Exception Under the Patents and Designs Act available online in Nigeria. A must-read for every citizen, corporate director, and legal researcher.